Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
This study has been completed.
University of Alabama at Birmingham
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Sonya Heath, MD, University of Alabama at Birmingham
First received: August 12, 2008
Last updated: March 11, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||September 2012|
|Primary Completion Date:||August 2012 (Final data collection date for primary outcome measure)|